ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 287 filers reported holding ALKERMES PLC in Q2 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,229 | +20.3% | 508 | +34.4% | 0.00% | +100.0% |
Q2 2023 | $11,831 | +43.7% | 378 | +29.5% | 0.00% | 0.0% |
Q1 2023 | $8,231 | -15.5% | 292 | -21.7% | 0.00% | 0.0% |
Q4 2022 | $9,746 | -30.4% | 373 | -40.7% | 0.00% | -50.0% |
Q3 2022 | $14,000 | -22.2% | 629 | +4.0% | 0.00% | -33.3% |
Q2 2022 | $18,000 | +12.5% | 605 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $16,000 | – | 605 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |